These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7985299

  • 1. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA, Chudnovskaia MV, Golovanov SA.
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hemodialysis and hemosorption in acute kidney failure].
    Kanus II.
    Urol Nefrol (Mosk); 1990; (1):13-6. PubMed ID: 2336750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
    Rinaudo JB, Gallice P, Crevat A, Saingra S, Murisasco A.
    Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Serum myoglobin levels in patients with acute and chronic renal insufficiency].
    Stefanović V, Miljković P, Lecić N, Bogićević M.
    Srp Arh Celok Lek; 1989 Oct; 117(5-6):301-11. PubMed ID: 2595459
    [Abstract] [Full Text] [Related]

  • 8. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F.
    Nefrologia; 2005 Oct; 25 Suppl 2():15-8. PubMed ID: 16050396
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV, Zakharchenko VN, Larionov SM, Naumov AG, Danilkov AP, Zakharova VD, Ivleva AI, Kudriavtsev IuV, Surikova TP.
    Urol Nefrol (Mosk); 1993 Oct; (4):34-7. PubMed ID: 8310565
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K, Walasek L, Kidawa Z, Lutz W.
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [Abstract] [Full Text] [Related]

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 17. [Hemosorption in the therapeutic complex for renal insufficiency in children].
    Isakov IuF, Burkov IV, Drozdov VA, Mosharov OP, Osipov IuN.
    Urol Nefrol (Mosk); 1980 Nov; (5):55-9. PubMed ID: 7423691
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.